Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Cannabis Stocks News
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
ALNY
Tag: ALNY
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had its Buy rating reiterated by Cantor...
ME Staff
-
April 9, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) gets upgraded to Overweight by Morgan Stanley...
ME Staff
-
March 5, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) gets upgraded to Overweight by Morgan Stanley
ME Staff
-
March 5, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had its Buy rating reiterated by Needham...
ME Staff
-
February 8, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has coverage initiated with a Neutral rating
ME Staff
-
January 23, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Entry into a Material...
ME Staff 8-k
-
January 15, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had its Buy rating reiterated by Cantor...
ME Staff
-
December 7, 2018
0
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported earnings of ($2.43) per share missing Walls...
ME Staff
-
November 7, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings of ($2.43) per share missing...
ME Staff
-
November 7, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had its Buy rating reiterated by BMO...
ME Staff
-
October 18, 2018
0
1
2
3
...
6
Page 1 of 6
/* */
// AST – IMS - [MarketExclusive_ROS]